Ignite Creation Date:
2025-12-24 @ 12:35 PM
Ignite Modification Date:
2026-02-01 @ 3:02 AM
Study NCT ID:
NCT05664061
Status:
UNKNOWN
Last Update Posted:
2023-03-01
First Post:
2022-12-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence With Clinical Endpoint Study of Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma
Sponsor:
Respirent Pharmaceuticals Co Ltd.
Organization: